Chiou et al., 1995 - Google Patents
Kaliuretic peptide: the most potent inhibitor of Na (+)-K+ ATPase of the atrial natriuretic peptidesChiou et al., 1995
- Document ID
- 1917303104902981191
- Author
- Chiou S
- Vesely D
- Publication year
- Publication venue
- Endocrinology
External Links
Snippet
The present investigation was designed to determine whether atrial natriuretic peptides consisting of amino acids 1-30 (ie long-acting natriuretic peptide), 31-67 (vessel dilator), 79- 98 (kaliuretic peptide), and 99-126 [atrial natriuretic factor (ANF)] of the 126 amino acid ANF …
- 230000002401 inhibitory effect 0 title abstract description 63
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chiou et al. | Kaliuretic peptide: the most potent inhibitor of Na (+)-K+ ATPase of the atrial natriuretic peptides | |
| Christov et al. | Plasma FGF23 levels increase rapidly after acute kidney injury | |
| Gunning et al. | Atrial natriuretic peptide (31-67) inhibits Na+ transport in rabbit inner medullary collecting duct cells. Role of prostaglandin E2. | |
| Kitamura et al. | Regional distribution of immunoreactive endothelin in porcine tissue: abundance in inner medulla of kidney | |
| Herzig et al. | Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine. | |
| KAMOI et al. | Atrial natriuretic peptide in patients with the syndrome of inappropriate antidiuretic hormone secretion and with diabetes insipidus | |
| Tsutomu et al. | Elevation of plasma endothelin concentrations during endotoxin shock in dogs | |
| Lafond et al. | Parathyroid hormone receptor in human placental syncytiotrophoblast brush border and basal plasma membranes | |
| Gutkowska et al. | Lung is an important source of atrial natriuretic factor in experimental cardiomyopathy. | |
| Gower Jr et al. | Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites | |
| Hildebrandt et al. | Comparison of renal actions of urodilatin and atrial natriuretic peptide | |
| Franz et al. | Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases | |
| Ationu et al. | Studies of cardiopulmonary bypass in children: implications for the regulation of brain natriuretic peptide | |
| Mimran et al. | Blood pressure, renin-angiotensin system and urinary kallikrein in a case of juxtaglomerular cell tumor | |
| Figueroa et al. | Cellular localisation of atrial natriuretic factor in the human kidney | |
| Carrithers et al. | Increased urinary excretion of uroguanylin in patients with congestive heart failure | |
| VESELY et al. | Increased circulating concentration of the N-terminus of the atrial natriuretic factor prohormone in persons with pheochromocytomas | |
| Kuwasako et al. | Increased plasma proadrenomedullin N-terminal 20 peptide in patients with essential hypertension | |
| Eckland et al. | Immunoreactive vasopressin and oxytocin in hypothalamo-hypophysial portal blood of the Brattleboro and Long–Evans rat: effect of adrenalectomy and dexamethasone | |
| Ladenson et al. | Plasma atriopeptin concentrations in hyperthyroidism, euthyroidism, and hypothyroidism: studies in man and rat | |
| Jamal et al. | Islet amyloid polypeptide-like immunoreactivity (amylin) in rats treated with dexamethasone and streptozotocin | |
| Heptner et al. | Exocrine pancreatic function after gastrectomy: Specificity of indirect tests | |
| Vesely et al. | Elevated atrial natriuretic peptides and early renal failure in type 2 diabetic Goto-Kakizaki rats | |
| Apa et al. | Endothelin-1 inhibits basal and human chorionic gonadotrophin-stimulated progesterone production. | |
| Ortola et al. | Endogenous ANP augments fractional excretion of Pi, Ca, and Na in rats with reduced renal mass |